Hepatic Arterial Embolization v. Chemoembolization in Patients with Liver Metastases of Digestive Neuroendocrine Tumors

#297

Introduction: Promising results have been reported using hepatic arterial chemoembolization (CE) or embolization (E) alone in patients with liver metastases of DET, but these modalities have not been compared.

Aim(s): In this prospective study, CE (doxorubicin 50 mg/m2) was compared to E in patients with unresectable and progressive liver mets of carcinoid tumors.

Materials and methods: Two procedures were performed with a 3-month interval. The main objective assessed was the rate of progression-free survival (PFS) at two years. Secondary objectives were overall survival (OS), tumor response (morphological and biological), and safety of the treatment.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: MAIRE F, Catherine L, Dermot O, Marie-Pierre V, Philippe R,

Keywords: liver metastases, carcinoid tumors, embolization, chemoembolization, prospective trial,